SCHEMBL21496513

SCHEMBL21496513

CC(=O)N(C(C)=O)C(C)C(C)N(C(C)=O)C(C)=O

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 4/20 0.39
CHRM4 P08173 4/20 0.39
CHRM5 P08912 4/20 0.39
CHRM1 P11229 4/20 0.39
CHRM3 P20309 4/20 0.39
TSHR P16473 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.32
THPO P40225 1/20 0.31
FFAR3 O14843 1/20 0.31
LCK P06239 1/20 0.31
FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7884699 0.79 CHRM2 (0.39) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9818007 0.79 CHRM2 (0.39) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL21513216 0.76 TRPV1 (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL21513663 0.76 CHRM2 (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9420014 0.71 TP53 (0.39) TP53FFAR3LCKFYN
SCHEMBL12534630 0.71 CHRM2 (0.35) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL8379480 0.69 CHRM2 (0.34) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL11685229 0.69 ALDH1A1 (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL12709698 0.69 CHRM2 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL8375316 0.69 CHRM2 (0.34) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3781661-B1 TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS DOW GLOBAL TECHNOLOGIES LLC (US) 2024-03-13 EP disclosed
US-11525106-B2 Tetraacetyldiamine and triacetyldiamine derivatives useful as bleach activators DOW GLOBAL TECHNOLOGIES LLC (US) 2022-12-13 US disclosed
US-11525106-B2 Tetraacetyldiamine and triacetyldiamine derivatives useful as bleach activators DOW GLOBAL TECHNOLOGIES LLC (US) 2022-12-13 US disclosed
US-20210155877-A1 TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS DOW GLOBAL TECHNOLOGIES LLC 2021-05-27 US disclosed
US-20210155877-A1 TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS DOW GLOBAL TECHNOLOGIES LLC 2021-05-27 US disclosed
EP-3781661-A1 TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS Dow Global Technologies, LLC (US) 2021-02-24 EP disclosed
WO-2019204184-A1 TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS DOW GLOBAL TECHNOLOGIES LLC (US) 2019-10-24 WO disclosed
WO-2019204184-A1 TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS DOW GLOBAL TECHNOLOGIES LLC (US) 2019-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11525106-B2 Tetraacetyldiamine and triacetyldiamine derivatives useful as bleach activators AADAC, DLAT, NAT10 CHRM2 1481/4885CHRM4 2003/4885CHRM5 1551/4885
US-20210155877-A1 TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS AADAC, DLAT, NAT10 CHRM2 1481/4885CHRM4 2003/4885CHRM5 1551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.